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'e global burden of chronic respiratory diseases such as
asthma and chronic obstructive pulmonary disease (COPD)
remains substantial despite available treatments and man-
agement guidelines. In this special issue, dedicated to in-
halation devices in respiratory disease, the advantages of the
inhalation route, the choice of device, and the importance of
educating patients in the correct inhalation technique are
examined.'e use of asthma medication by recreational and
elite athletes is also reviewed.
Inhaled medication is the mainstay of treatment for the
management of these diseases, conferring a number of
advantages, such as direct delivery of the therapeutic drug to
the lung in high concentrations, a rapid onset of action, and
minimal systemic side eﬀects. However, as detailed in the
review by J. M. Borghardt et al., these beneﬁts can only be
achieved if drug design considers the properties of inhaled
drugs, the device and formulation characteristics, and the
inﬂuence of patient characteristics. An understanding of the
lung and all its associated kinetic processes is necessary to
overcome the complex challenges of the inhalational route of
administration.
'e importance of matching the inhaler device to the
patient is expanded in the review by A. Kaplan and D. Price,
who discuss the role of the primary care physician in in-
volving the patient in the selection of an appropriate inhaler.
'is includes taking into account patient-related factors
such as age, dexterity, and cognitive ability, as well as
considering patient preferences and perceptions regarding
inhaler choice. Having chosen the appropriate device in
consultation with their patient, it is vital that the primary
care physician educates and trains the patient in its correct
use, as well as regularly reviews their technique, in order to
minimize common patient errors in inhalation and ensure
eﬀective use of inhaler devices among their patients. Treating
infants and very young children with asthma can be chal-
lenging, as the patients are unable to coordinate an in-
spiratory maneuver with an actuation of an inhaler. A more
suitable method of aerosol delivery is via spacers through
a facemask. C. Kofman and A. Teper investigated the eﬃcacy
of the steroid ﬂuticasone propionate when delivered via
nonvalved spacers (NVS) with MDI as compared to valved
holding chambers (VHC) with MDI in a small study of
children with asthma aged 6 to 20 months. 'ey conclude
that long-term treatment with inhaled steroids is more ef-
fective when administered by MDI and VHC in infants with
asthma.
All touchpoints between patients and healthcare pro-
fessionals should be optimized to ensure support is provided
to the patient. Given that nurse practitioners, both specialist
and nonspecialist, are often a primary point of contact for
patients with asthma and COPD, they can be responsible for
the ongoing evaluation of asthma control, COPD disease
progression, and treatment success. 'us, they are in a key
position to recognize poor disease control, provide patient
education on topics such as inhaler technique, and en-
courage treatment adherence, all whilst considering patients’
views and preferences. J. Scullion presents the nurse prac-
titioner’s perspective and describes the nursing cornerstones
of inhaler education—“Know it,” “Show it,” “Teach it,” and
“Review it.” Linked to the reinforcement of inhaler tech-
nique that nurses can provide is the additional consideration
of the pharmacist’s role in this regard. M. Toumas-Shehata
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et al. studied inhaler device technique education mainte-
nance over time in pharmacy undergraduates. 'ey dem-
onstrate the importance of repeated training and the
consolidation of skills through the training of others and
experience with instructing patients in inhaler use.
'e needs of patients with respiratory failure also need
consideration. Stopping noninvasive ventilation (NIV) in
order to administer the corticosteroids and bronchodilators
required to treat their condition via inhalers or nebulizers
may result in a rapid deterioration of the patient’s condition.
P. Rzepka-Wrona et al. review the current literature de-
scribing small studies where recommendations for nebuli-
zation techniques and mask types are given for aerosol
therapy coupled with NIV in this special patient population.
However, they identify that there remains a need for more
precise data coming from large prospective and well-
planned real-life studies on nebulization techniques in pa-
tients receiving NIV.
Real-life studies are also important to identify diﬀerent
groups of patients with asthma and diﬀerent asthma phe-
notypes. Asthma is known to be prevalent in elite endurance
athletes, but little is known of its prevalence in competitive
recreational athletes. Analysis of the responses to an online
survey sent to Swedish endurance athletes indicates that self-
reported asthma appears to be higher in this population than
in the general Swedish population. 'is study by A. Na¨sman
et al. of 10,076 athletes concludes that there appears to be an
association between high physical activity and self-reported
asthma, with a large proportion of recreational athletes using
asthma medications regularly. H. Persson et al. report
a study in Swedish elite athletes with asthma, where more
than three-quarters of those that responded to a postal
questionnaire reported using asthma medication, and about
one-third reported using bronchodilators and/or inhaled
corticosteroids daily. 'is suggests that these athletes may
have uncontrolled asthma and, as with all asthma patients,
should be monitored regularly.
'is special issue, about inhalation in respiratory dis-
eases, brings into focus the importance of correct inhaler
choice, patient education, and the role played by primary
care practitioners, nurses, and pharmacists in reinforcing
patient education and inhaler technique. It also raises some
interesting questions of how to ensure all patients receive the
necessary training from healthcare contacts and how speciﬁc
subsets of respiratory disease treatment require more at-
tention, from treating the youngest patients, to those re-
quiring NIV, through to elite athletes.
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